by Shelley Ross | Oct 1, 2023 | Latest News
Miami/September 29, 2023/A phase II clinical trial hoping to silence the deadliest form of pancreatic cancer has started enrolling patients at SUNY Downstate Medical Center in Brooklyn, N.Y., The Cure Alliance announced today. Pancreatic Ductal Adenocarcinoma Cancer...
by Shelley Ross | Nov 20, 2022 | Latest News
Since 2015, I have served as President of The Cure Alliance, a boutique 501(C)(3) non-profit with a mission to help research scientists accelerate the pace of their discoveries from the lab to the patient’s bedside. In the very beginning, Dr. F. Charles Brunicardi...
by Shelley Ross | May 19, 2022 | Press Releases
Full sponsorship of the phase II trial of UC-MS infusions to treat severe lung damage in COVID-19 ARDS has been successfully transferred to a corporate entity which will soon begin a large randomized double-blind multi-site trial. The initial research for the...
by Shelley Ross | May 7, 2020 | Press Releases
FOR IMMEDIATE RELEASE: Miami, Fla. (May 6, 2020) – The Diabetes Research Institute Foundation (DRIF) today announced a donation of $3 million from North America’s Building Trades Unions (NABTU), to support the clinical trial of umbilical cord mesenchymal stem cells...
by Shelley Ross | May 5, 2020 | Latest News, Press Releases
FOR IMMEDIATE RELEASE May 5, 2020: The Cure Alliance announces the start of planning for phase II of the clinical trial of umbilical cord-derived mesenchymal stem cells (UC-MSCs) to block the life-threatening lung inflammation that accompanies severe cases of...
